About This Role
A fractional CMO role guiding clinical strategy and medical oversight for EPRA-0322, a biologic targeting anemia in chronic kidney disease, across development, regulatory, and medical affairs functions.
A fractional CMO role guiding clinical strategy and medical oversight for EPRA-0322, a biologic targeting anemia in chronic kidney disease, across development, regulatory, and medical affairs functions.